The Wall Street Journal has yet another story this morning about Elon Musk’s drug use —“ketamine recreationally through a nasal spray bottle,” “ecstasy from a water bottle,” among other substances and delivery methods — this time concerning how he does them with board members of his various companies, some of whom have amassed very valuable stock options in their time there. (Musk didn’t comment to the Journal for its story.) Some of them are worried that Musk is going to tank the value of those companies, but they’re scared to speak up because they don’t want to get on his bad side.